Influenza News and Research

Latest Influenza News and Research

Immunity based upon “mild" Omicron infection is weak for Omicron reinfection

Researchers evaluate antibody responses in vaccinated individuals who subsequently developed Delta and Omicron SARS-CoV-2 breakthrough infections.

30 Jan 2022

New app and lab kit transform a smartphone into COVID-19 / flu detection system

In a potential game changer for COVID-19 pandemic control efforts, a new cell phone app and lab kit have transformed a smartphone into a COVID-19 / flu detection system.

29 Jan 2022

Intranasal vaccine with nanoparticles offers strong protection against influenza viruses

An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

29 Jan 2022

Mix-and-match of COVID-19 vaccine boosters found to be safe and effective

In adults who had previously received a full regimen of a COVID-19 vaccine approved or authorized by the Food and Drug Administration (FDA), an additional dose of any of these COVID-19 vaccines was safe and prompted an immune response, according to study findings published Jan. 26 in The New England Journal of Medicine.

28 Jan 2022

In super-vaxxed Vermont, covid strikes — but packs far less punch

Even Eden, a snow-covered paradise in northern Vermont, is poisoned by omicron.

28 Jan 2022

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

Researchers discuss the contributions that have been provided by magnetic nanoparticles for the molecular diagnosis of human viruses.

28 Jan 2022

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

In a new study, researchers hypothesized and developed broad-spectrum SARS-CoV-2 inhibitors, ReconnAbs, by modifying the existing non-neutralizing antibodies targeted towards the highly conserved epitopes of the SARS-CoV-2 spike (S) protein combined with a receptor-blocking component.

28 Jan 2022

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Researchers investigate the possible efficacy of IFN-λ in the context of SARS-CoV-2 infection in mice.

28 Jan 2022

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

In a new study, researchers analyzed the effects of multi-nutrient supplementation on SARS-CoV-2 vaccine efficacy and the overall improvement of respiratory and muscle function in elderly COVID-19 patients.

27 Jan 2022

Hospitalization for COVID-19 may increase the risk of later readmission or death

People who had been hospitalized for COVID-19 in 2020 - and survived for at least one week after discharge - were more than twice as likely to die or be readmitted to the hospital in the next several months compared to the general population, according to new research in PLOS Medicine.

26 Jan 2022

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the U.S. Food and Drug Administration, an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results reported in The New England Journal of Medicine.

26 Jan 2022

Study demonstrates differential alternative splicing in betacoronaviruses

A new study investigates whether the proportion of ribosomal genes displaying differential gene expression and differential alternative splicing differed between three betacoronaviruses and six other viruses and bacteria.

26 Jan 2022

Effects of the Omicron spike amino acid changes in the interaction with human ACE2 receptor or human antibodies

A recent study analyzed the effects of the interaction between SARS-CoV-2 Omicron spike amino acid and the human ACE2 receptor or with human antibodies.

26 Jan 2022

People hospitalized for COVID-19 have elevated risk of later readmission or death

A large study conducted in England found that, compared to the general population, people who had been hospitalized for COVID-19 - and survived for at least one week after discharge - were more than twice as likely to die or be readmitted to the hospital in the next several months.

25 Jan 2022

Influenza News and Research

Latest Influenza News and Research

Immunity based upon “mild" Omicron infection is weak for Omicron reinfection

New app and lab kit transform a smartphone into COVID-19 / flu detection system

Intranasal vaccine with nanoparticles offers strong protection against influenza viruses

Mix-and-match of COVID-19 vaccine boosters found to be safe and effective

In super-vaxxed Vermont, covid strikes — but packs far less punch

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

Hospitalization for COVID-19 may increase the risk of later readmission or death

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

Study demonstrates differential alternative splicing in betacoronaviruses

Effects of the Omicron spike amino acid changes in the interaction with human ACE2 receptor or human antibodies

People hospitalized for COVID-19 have elevated risk of later readmission or death

Scientists find reduced vaccine efficacy against Omicron in South Africa and 50 other countries

Study opens the door to a new approach to attacking herpesviruses

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Influenza News and Research

Latest Influenza News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in